Evidence map›Paper›PMID 35995910›Full record

ArticleProbiotics and antimicrobial proteins2023

Bifidobacterium animalis sup F1-7 Acts as an Effective Activator to Regulate Immune Response Via Casepase-3 and Bak of FAS/CD95 Pathway.

Youyou Lu, Xi Liang, Yeting Wu, Ruiqi Wang, Tongjie Liu, Huaxi Yi, Zhuang Yu, Zhe Zhang, Pimin Gong, Lanwei Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Recent advances in probiotication of fruit and vegetable juices.Journal of advanced veterinary and animal research · 2023
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Youyou LuCollege of Food Science and Technology; Key Laboratory of Environment Correlative Dietology, Ministry of Education, Huazhong Agricultural University, Wuhan, 430070, China.
Xi LiangCollege of Food Science and Engineering, Ocean University of China, Qingdao, 266000, China.
Yeting WuCollege of Food Science and Engineering, Ocean University of China, Qingdao, 266000, China.
Ruiqi WangCollege of Food Science and Engineering, Ocean University of China, Qingdao, 266000, China.
Tongjie LiuCollege of Food Science and Engineering, Ocean University of China, Qingdao, 266000, China.
Huaxi YiCollege of Food Science and Engineering, Ocean University of China, Qingdao, 266000, China.
Zhuang YuAffiliated Hospital of Qingdao University, Qingdao, 266042, China.
Zhe ZhangCollege of Food Science and Engineering, Ocean University of China, Qingdao, 266000, China.
Pimin GongCollege of Food Science and Engineering, Ocean University of China, Qingdao, 266000, China. gongpimin@ouc.edu.cn.
Lanwei ZhangCollege of Food Science and Engineering, Ocean University of China, Qingdao, 266000, China. zhanglanwei@ouc.edu.cn.ORCID http://orcid.org/0000-0003-3459-2975
Ocean University of China · CNHuazhong Agricultural University · CNQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intestinal microecology was closely related to immune regulation, but the related mechanism was still unclear. This study aimed to reveal how microorganisms improved immune response via casepase-3 and Bak of FAS/CD95 pathway. Bifidobacterium animalis F1-7 inhibited the melanoma B16-F10 cells in vitro effectively; had a potent anticancer effect of lung cancer mice; effectively improved the spleen immune index and CD3

Indexed as

ApoptosisBifidobacterium animalisAnimalsCaspase 8fas ReceptorImmunityMiceSignal TransductionCaspase 8fas ReceptorB. animalis F1-7Effective activatorFAS/CD95 pathwayImmune responsePotentially beneficial microorganisms

Identifiers

PMID35995910
OpenAlexW4294365629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.